CaMKIIβ knockdown decreases store-operated calcium entry in hippocampal dendritic spines

Nikita Zernov1, Ilya Bezprozvanny1,2, Elena Popugaeva1

  • 1Peter the Great St.Petersburg Polytechnic University, Laboratory of Molecular Neurodegeneration, St.Petersburg, Russia.

IBRO Neuroscience Reports
|January 26, 2022
PubMed

Insights

Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition reduces neuronal store-operated calcium entry (nSOCE). CaMKIIβ knockdown also decreases nSOCE and leads to mushroom spine loss, suggesting a role in Alzheimer's disease pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) pathogenesis involves Calcium/calmodulin-dependent protein kinase II (CaMKII) and neuronal store-operated calcium entry (nSOCE).
  • nSOCE regulates dendritic spine morphology, crucial for synaptic plasticity and memory formation.
  • CaMKII is essential for long-term potentiation, a cellular mechanism underlying memory.

Purpose of the Study:

  • To investigate the relationship between CaMKII activity and nSOCE in primary hippocampal neurons.
  • To determine the role of CaMKIIβ in regulating nSOCE and dendritic spine morphology.

Main Methods:

  • Inhibition of CaMKII kinase activity using KN-62.
  • Knockdown of CaMKIIβ expression.
  • Measurement of nSOCE amplitude in neuronal soma and dendritic spines.
  • Assessment of dendritic spine morphology in primary hippocampal cultures.

Main Results:

  • Inhibition of CaMKII by KN-62 decreased nSOCE amplitude in the soma of primary hippocampal neurons.
  • CaMKIIβ knockdown resulted in the downregulation of nSOCE in dendritic spines.
  • CaMKIIβ knockdown led to mushroom spine loss, potentially due to reduced dendritic spine head size.

Conclusions:

  • CaMKII activity is critical for regulating nSOCE in neurons.
  • CaMKIIβ plays a significant role in maintaining nSOCE and dendritic spine stability.
  • These findings suggest a potential therapeutic target for Alzheimer's disease by modulating CaMKII and nSOCE pathways.